Laura Segalés

Universitat Pompeu Fabra — Spain

Medicine · Health Sciences

8h-index150citations14works1.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(9), Prostate Cancer Diagnosis and Treatment(6), Cancer, Lipids, and Metabolism(4), Nutritional Studies and Diet(2), PARP inhibition in cancer therapy(2)

Publications14 total

Letter to the Editor (Correspondence): Re: Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer
Laboratory Investigation·2026
Uncovering the role of ETS2 in prostate cancer pathogenesis: relationship with p53 and ERG
Molecular Biology Reports·2026
Muscle disease in severe COVID-19 patients: a microangiopathic myopathy
Ultrastructural Pathology·2025· 1 cited
Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer
Laboratory Investigation·2025· 3 citedOpen Access
The Mediterranean Diet in Pregnancy: Implications for Maternal Brain Morphometry in a Secondary Analysis of the IMPACT BCN Randomized Clinical Trial
Nutrients·2024· 2 citedOpen Access
Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2023· 3 citedOpen Access
Effects of Mediterranean diet or mindfulness-based stress reduction on fetal and neonatal brain development: a secondary analysis of a randomized clinical trial
American Journal of Obstetrics & Gynecology MFM·2023· 16 citedOpen Access
An automatic pipeline for atlas-based fetal and neonatal brain segmentation and analysis
Computer Methods and Programs in Biomedicine·2023· 12 citedOpen Access
Maternal Dietary Inflammatory Index during Pregnancy Is Associated with Perinatal Outcomes: Results from the IMPACT BCN Trial
Nutrients·2022· 20 citedOpen Access
SPOP and<i>CHD1</i>alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence
The Prostate·2021· 14 citedOpen Access
Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2019· 26 cited
<i>SPOP</i> and <i>FOXA1</i> mutations are associated with PSA recurrence in <i>ERG</i> wt tumors, and <i>SPOP</i> downregulation with <i>ERG</i>‐rearranged prostate cancer
The Prostate·2019· 20 cited
Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2019· 10 cited
ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression
Oncotarget·2017· 23 citedOpen Access

Frequent Co-authors

Núria Juanpere(8), Josep Lloreta(8), Silvia Hernández‐Llodrà(7), Lluís Fumadó(7), Lluís Cecchini(7), Marta Lorenzo(6), Joaquim Bellmunt(5), Alejo Rodríguez‐Vida(4), F. Crovetto(4), A. Nakaki(4), F. Crispi(4), E. Gratacós(4), Raquel Albero‐González(3), Rosa Casas(3), L. Youssef(3), Eduard Vieta(3), Ramón Estruch(3), Silvia de Muga(2), Laia Serrano(2), Sara Castro‐Barquero(2)